Rbd Of Spike

Anti-Spike-RBD-fully-human-mAb(IgG)

E24AHA001 Human,-Human-IgG1.Affinity:(mol)4.15*10-10(Fortebio),-1.07-nM(ELISA).-FACs-Blocking:-0.892-nM-
EUR 416.5
Description: Human, Human IgG1.Affinity: (mol) 4.15*10-10 (Fortebio), 1.07 nM (ELISA) . FACs Blocking: 0.892 nM

Human IgG antibody Laboratories manufactures the rbd of spike reagents distributed by Genprice. The Rbd Of Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Rbd products are available in stock. Specificity: Rbd Category: Of Group: Spike

Anti-Spike-RBD-fully-human-mAb(IgG)

Humanized-Monoclonal-Antibody.-human-IgG1.-Affinity:0.762-nM(By-ELISA)
EUR 416.5
Description: Humanized Monoclonal Antibody. human IgG1. Affinity:0.762 nM (By ELISA)

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike Trimer)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike S1)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

JBS True Blue

300µl
EUR 13.7

Mouse Monoclonal Anti-SARS Spike IgG

50 ug
EUR 562.8

Spike information

SARS-CoV-2 Spike RBD Titer Assay Kit

RAS-A021 96tests
EUR 631.3
Description: It's been reported that coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Active Recombinant SARS-CoV Spike RBD Protein

RP01299 100μg
EUR 520

Active Recombinant SARS-CoV Spike RBD Protein

RP01304 500μg
EUR 42.25

Active Recombinant MERS-CoV Spike RBD Protein

RP01305 10μg
EUR 539.5

SARS-CoV-2 Spike RBD (N501Y) Rabbit mAb

A21254 20μL
EUR 778.7
Description: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human SR-B2/SR-B2/LIMPII (Q14108).

SARS-CoV-2 Spike RBD Antibody Pair 1

55R-2273 1 set
EUR 833
Description: SARS-CoV-2 Spike RBD Antibody Pair 1

SARS-CoV-2 Spike RBD Protein ELISA Kit

RK04135 96T
EUR 280

SARS-CoV-2 (COVID-19) Spike RBD Antibody

9087-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike RBD Antibody

9087-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1 each Ask for price

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1-100 100
EUR 148.12
Description: Primary VHH single domain antibody

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1-1000 1000
EUR 880.6
Description: Primary VHH single domain antibody

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1-2000 2000
EUR 1565.2
Description: Primary VHH single domain antibody

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1-250 250
EUR 246.17
Description: Primary VHH single domain antibody

anti-SARS-CoV-2 spike RBD VHH antibody

JOT0007-1-50 50
EUR 89.54
Description: Primary VHH single domain antibody

SARS-CoV-2 Spike RBD (BA.2.12.1) ELISA Kit

RAS-A130 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

Spike-protein-of-SARS-CoV-2(2019-nCoV)(RBD,-Fc-Tag)

E25-2020PRBDFC 2019-nCoV-Recombinant-Protein-Antigen
EUR 346.5
Description: 2019-nCoV Recombinant Protein Antigen